share_log

国家药监局综合司发布《支持港澳药品上市许可持有人在大湾区内地9市生产药品实施方案》和《支持港澳医疗器械注册人在大湾区内地9市生产医疗器械实施方案》

The General Department of the State Drug Administration issued the implementation Plan for supporting Hong Kong and Macao Drug listing licensees to produce drugs in 9 mainland cities in the Greater Bay area and the implementation Plan for supporting Hong

Breakings ·  Jun 29, 2022 17:30
The General Department of the State Drug Administration issued the implementation Plan for supporting Hong Kong and Macao Drug listing licensees to produce drugs in 9 mainland cities in the Greater Bay area and the implementation Plan for supporting Hong Kong and Macao Medical device registrants to produce Medical Devices in 9 cities in the Great Bay area. Permit holders of Hong Kong and Macao drug listing licenses to entrust production across borders in the mainland of the Greater Bay area, further promote the deep integration of Guangdong-Hong Kong-Macau Greater Bay Area's biomedical industry, and realize the common development of Guangdong-Hong Kong-Macau Greater Bay Area's pharmaceutical industry. To support the production of medical devices held by Hong Kong and Macao medical device registrants in qualified enterprises in 9 cities in the mainland of Guangdong-Hong Kong-Macau Greater Bay Area.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment